Pharma cold chain: a calculated risk
The combination of the rapid globalisation of the pharmaceuticals market and growing demand for complex, fragile and temperature-sensitive…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
28 Mar 13
The combination of the rapid globalisation of the pharmaceuticals market and growing demand for complex, fragile and temperature-sensitive…
28 Mar 13
Between 2006 and 2009, 7.5 million fake drugs were seized at EU borders, prompting Big Pharma to step…
28 Mar 13
Pharmaceutical packaging plays a pivotal role in improving compliance, reducing counterfeiting and creating brand equity. However, with budgets…
28 Mar 13
As pharmaceuticals become more complex, developing efficient delivery methods is vital to ensure therapeutic efficacy. Sudip Das of…
The cold chain faces many challenges – temperature integrity, data monitoring, storage and regulation among them – and…
27 Mar 13
As the preferred format for regulatory submissions to the FDA, the eCTD offers strategic advantages to sponsor organisations.…
27 Mar 13
Mollie Shields-Uehling, president and CEO of SAFE-BioPharma Association, explains how the industry’s interests in collaboration and cloud computing…
27 Mar 13
Paul Ludorf of Rottapharm looks at how the use of software systems by the first generation of digital…
26 Mar 13
Following a period of decline in delivery, and in anticipation of major regulatory ructions, PwC’s Steve Arlington, Myrto…
11 Mar 13
Pharmaceutical and biotechnology companies are increasingly considering adaptive strategies in clinical trials, but what do they entail? Dr…